Batoul Khoundabi
Research Subjects
Research Interests
Batoul Khoundabi has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Ahmad Soltan
Iran-Helal Institute of Applied Science and Technology, Tehran, Iran
1 shared publicationAhmad Soltani
MD, Ph.D in Disaster & Emergencies Health, Associated at Health in Emergency & Disaster Research Center Tehran, Research Center for Emergency and Disaster Resilience, Red Recent Society of the Islamic Republic of Iran, I.R Iran
1 shared publication- Alireza Bagheri
Department of Internal Medicine, Hamadan university of Medical Sciences, Hamadan, Iran
1 shared publication - Fanak Fahimi
Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Clin Pharm, Tehran, Iran
1 shared publication - Khadijeh Raeisi
School of Electrical Engineering, K.N.Toosi University of Technology, Tehran, Iran
1 shared publication - Majid Malekmohammad
Tracheal Disease Research Center, National Research Institute of Tuberculosisand Lung Diseases (NRITLD), Shahid Beheshti University of Medical Science, Tehran, Iran
1 shared publication
Latest Publications
- 1 January 2021
- Published by Negah Scientific Publisher in Health in Emergencies & Disasters Quarterly
- Vol. 6 (2) , 63-66
Initial Steps to Achieve a Disaster-related Statistics Framework in Iran: An Executive Proposal
- 1 January 2021
- Published by Negah Scientific Publisher in Health in Emergencies & Disasters Quarterly
- Vol. 6 (2) , 63-66
Initial Steps to Achieve a Disaster-related Statistics Framework in Iran: An Executive Proposal
- Open Access
- 1 September 2020
- Vol. 2 (3) , 8-14
Statistical Modeling of the Beginning and End of Relief Time by Red Crescent in Earthquakes between “1395-1396”: a Survival Study
- 1 September 2020
- Vol. 2 (3) , 8-14
Open AccessStatistical Modeling of the Beginning and End of Relief Time by Red Crescent in Earthquakes between “1395-1396”: a Survival Study
- 5 December 2019
- Published by Springer Nature in Sleep and Breathing
- Vol. 24 (4) , 1417-1425
The effect of acetazolamide on the improvement of central apnea caused by abusing opioid drugs in the clinical trial
Acetazolamide is utilized as a treatment which falls effective in treating some type of CSA. Hence, it might be effective as far as opium addicts who suffer from CSA are concerned.
- 5 December 2019
- Published by Springer Nature in Sleep and Breathing
- Vol. 24 (4) , 1417-1425
The effect of acetazolamide on the improvement of central apnea caused by abusing opioid drugs in the clinical trial
Acetazolamide is utilized as a treatment which falls effective in treating some type of CSA. Hence, it might be effective as far as opium addicts who suffer from CSA are concerned.